Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

OLIG1 Mouse anti-Human, Clone: 2A4, Invitrogen™

Mouse Monoclonal Antibody

Manufacturer:  Invitrogen MA522956

Catalog No. PIMA522956


Add to cart

Description

Description

Peptide Sequence: PDAKEEQQQQ LRRKINSRER KRMQDLNLAM DALREVILPY SAAHCQGAPG RKLSKIATLL LARNYILLLG SSLQELRRAL

Promotes formation and maturation of oligodendrocytes, especially within the brain. Cooperates with OLIG2 to establish the pMN domain of the embryonic neural tube (By similarity).
Specifications

Specifications

OLIG1
Monoclonal
0.2-1.0 mg/mL
PBS with no preservative; pH 7.4
Q8TAK6
olig1, olig2, olig3, Oligodendrocyte transcription factor 2 antibody, Oligo2 antibody, Basic helix-loop-helix protein class B 1 antibody, Protein kinase C-binding protein, Oligodendrocyte transcription factor 1, Oligo1, Class B basic helix-loop-helix protein 6, bHLHb6, Class E basic helix-loop-helix protein 21, bHLHe21, BHLHB6, BHLHE21Oligodendrocyte transcription factor 3, Class B basic helix-loop-helix protein 7, bHLHb7, Class E basic helix-loop-helix protein 20, bHLHe20, BHLHB7, BHLHE20
Mouse
IgG2a, kappa
100 μg
-20° C, Avoid Freeze/Thaw Cycles
Primary
116448
ELISA, Immunoprecipitation, Western Blot
2A4
Unconjugated
OLIG1
Liquid
OLIG1
OLIG1 (NP_620450.1, 80 a.a. ∽ 159 a.a) full length recombit protein with GST tag. MW of the GST tag alone is 26 KDa.
Affinity chromatography
RUO
Antibody
Monoclonal
Human
Documents
Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit